Osteogenesis Imperfecta clinical trials at UCSF

1 in progress, 0 open to eligible people

Study to Assess Dose, Efficacy and Safety of Setrusumab in Participants With Osteogenesis Imperfecta
Sorry, not currently recruiting here
The primary objectives of the study are to identify a setrusumab dosing strategy in participants with OI and to evaluate the effect of setrusumab vs placebo on reduction in fracture rate.
San Francisco, California and other locations

Last updated: October 31, 2022